51. Increased cyclin B1/CDC 2 kinase activity and phosphorylation of Bcl-2 associated with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells
- Author
-
T-S. Huang, Wen-Kuang Yang, and C-H. Shu
- Subjects
Pharmacology ,Cancer Research ,Kinase ,Biochemistry (medical) ,Clinical Biochemistry ,Pharmaceutical Science ,Cell Biology ,Biology ,medicine.disease ,stomatognathic diseases ,chemistry.chemical_compound ,Nasopharyngeal carcinoma ,Paclitaxel ,chemistry ,Apoptosis ,otorhinolaryngologic diseases ,medicine ,Cancer research ,Cytotoxic T cell ,Kinase activity ,Cyclin B1 ,Cyclin - Abstract
Paclitaxel is a potential cancer chemotherapeutic agent for ovary, breast, and head and neck cancers; its effects on nasopharyngeal carcinoma (NPC) have not been reported previously. This study investigated the cytotoxic mechanism of paclitaxel in two NPC cell lines, NPC-TW01 and NPC-TW04. NPC cells treated with pacli-taxel showed convoluted nuclei, condensed chromatin and decreased cellular and nuclear volume, and also exhibited genomic DNA degradation into multiple oligonucleosomal fragments, suggesting that pacli-taxel induced apoptosis in these cells. The effects of paclitaxel on apoptosis-related proteins including Bcl-2, Bax and CDC 2 were also detected. Although the levels of Bcl-2 and Bax were not changed in NPC cells following treatment with 5 nM-1 μM of paclitaxel, phosphorylation of Bcl-2 was significantly observed in the cells treated with 1 μM of paclitaxel for 12 hours. In addition, cyclin B1-associated CDC 2 kinase was highly activated in the NPC cells exposed to paclitaxel even at low (5 nM) concentration, and this result is associated with the finding that low concentration of paclitaxel is able to induce apoptosis in NPC cells.
- Published
- 1996
- Full Text
- View/download PDF